Maple Grove, Minn.-based Conventus Orthopaedics borrowed a $12 million from Horizon Technology Finance, according to Hartford Business.
Spinal Tech
Zimmer Biomet earned FDA clearance for its Sidus Stem-Free Shoulder System.
The global arthroscopic devices market is expected to grow at a compound annual growth rate of 5.1 percent through 2022, according to a Persistence Market Research report.
OrthoPediatrics unveiled its Titanium PediPlates, expanding the company’s profile to 24 surgical systems.
North Naples, Fla.-based Arthrex broke ground on its $73.4 million headquarter expansion, according to Naples Daily News.
Advertisement
Zyga Technology presented publication on the first 50 patients in its EVoluSIon clinical study. The 250 patient at 40 site study is evaluating long-term fusion and pain reduction in patients that undergo procedures using the SImmentry Sacroiliac Joint Fusion System.
Medovex converted its FDA Investigational Device Exemption submission to a pre-submission.
In 2009, The New England Journal of Medicine published two studies, the INVEST and Australian trials, that cast doubt on the benefits of vertebral augmentation.1,2 The analyses found no significant differences in pain relief between vertebroplasty and a sham intervention. These…
New developments do not only improve patient satisfaction, but can also improve surgeon satisfaction. Anthony Zannis, director of upstream marketing at Mizuho OSI, explains how technology can improve patient outcomes as well as what patients and surgeons can expect from…
Here are three key notes on orthopedic and spine device companies from the past week.